Stay updated with the latest fintech market trends, insights, and analysis. Explore breaking news, market movements, and expert opinions to make informed decisions in the ever-evolving financial technology landscape
Meta shares rise after a solid earnings report and optimism about AI-related growth opportunities. Technical analysis suggests short-term bullish targets around $755 and longer-term targets around $935. Key support levels to monitor on pullbacks are $632 and $600.
Published on: February 04, 2025, 07:01 PM UTC
Robinhood (HOOD) ordered to stop offering sports betting contracts by Commodity Futures Trading Commission (CFTC)
Published on: February 04, 2025, 07:00 PM UTC
Historical U.S. tariffs, including the 2018 washing machine tariff, reveal potential economic impacts of trade wars such as increased prices, limited job creation, and damage to the economy.
Published on: February 04, 2025, 06:06 PM UTC
Treasury brings on two people connected to the so-called Department of Government Efficiency, Tom Krause and Marko Elez, to meet with staff responsible for the government payments system and database.
Published on: February 04, 2025, 06:06 PM UTC
Xylem (XYL) stock jumped 7.2% today after reporting strong Q4 results. While full-year guidance missed, the market reacted positively to the EPS and revenue beat. XYL remains 10.9% below its 52-week high of $145.95.
Published on: February 04, 2025, 06:05 PM UTC
J&J Snack Foods (JJSF) shares dropped 11.1% premarket after the company reported underwhelming Q4 results. Gross margin missed estimates, leading to an EPS shortfall. Read more on JJSF's performance and market impact.
Published on: February 04, 2025, 06:04 PM UTC
Footwear and apparel tariffs go into effect, increasing costs for US consumers. Companies like Kontoor Brands (KTB), Warby Parker (WRBY), Skechers (SKX), and Crocs (CROX) may see earnings decline. Retailers strategize in "tariff war rooms" to mitigate margin erosion and protect their profits.
Published on: February 04, 2025, 06:03 PM UTC
Pfizer (PFE) reports Q4 and full-year 2024 earnings, beating Wall Street expectations. Revenue grew 7% to $63.6 billion for the year, while EPS of $3.12 exceeded estimates. Despite facing headwinds like pipeline challenges and Medicare price negotiations, Pfizer plans to cut costs and enhance shareholder value in 2025.
Published on: February 04, 2025, 06:03 PM UTC
Job openings fell to 7.6 million in December, the lowest since September, as hiring slowed and investors monitor the labor market for signs of cooling.
Published on: February 04, 2025, 06:03 PM UTC
Trump's tariffs are a departure from his previous approach, with higher duties, a wider range of consumer goods affected, and a use of tariffs as leverage for other concessions. China, Canada and Mexico are preparing to retaliate, and the economic effects are expected to be felt quickly.
Published on: February 04, 2025, 06:02 PM UTC